Prism Medico and Pharmacy
- Market cap
- ₹ 42 Cr.
- P/E
- 251.2x
- P/B
- 1.23x
- 52-week range
- 15.51 – 35.99
- ROE
- 2%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Finance
- Industry
- Non Banking Financial Company (NBFC)
- Listed on
- BSE
About
Prism Medico and Pharmacy Limited is an India-based company, which is engaged in wholesaling and retailing of straw, fodder, and other animal/poultry feed. The Company is in the business of manufacturing, buying, dealing, exporting, importing, and trading, distributing, acting as wholesaler, retailer, suppliers, selling agent, buying agent, repackers, analytical chemists, druggists, refiners, processors, merchants, and stockiest in all types of cases kinds/nature, chemicals, serums, chemical products, antibiotics, medicines, drugs, pharmaceuticals pesticide, dyes, soaps oil, perfumes, cosmetic, patent medicine, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Non Banking Financial Company (NBFC): 288 companies →Prism Medico and Pharmacy against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)251.2 against a typical 22.5: pricier than most peers (1st = cheapest).247th of 284
- Sales growth−100% against a typical +18.3% from a year earlier.251st of 259
- Profit growth−109.1% against a typical +20.2% from a year earlier.199th of 214
- Share price, 3 months+23.9% against a typical −4.2%.35th of 258
- Size₹ 42 Cr. market value against a typical ₹ 43 Cr. (1st = largest).141st of 269
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Financing Profit | −0 | 0 | −0 | −0 | 0 | −0 | 0 | 1 | −0 | −0 | −0 | −0 |
| Financing Margin % | −200% | 6.9% | −113.3% | −150% | 3.5% | −4.8% | 14.3% | 40.9% | −20% | −28.6% | −42.9% | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −0 | 0 | −0 | −0 | 0 | −0 | 0 | 1 | −0 | −0 | −0 | −0 |
| Tax % | 0% | 0% | −14.3% | 0% | 0% | 0% | −100% | −1.5% | 0% | 0% | 100% | 0% |
| Net Profit | −0 | 0 | −0 | −0 | 0 | −0 | 0 | 1 | −0 | −0 | −0 | −0 |
| EPS in Rs | −0.08 | 0.31 | −0.12 | −0.15 | 0.02 | −0.02 | 0.07 | 1.09 | −0.13 | −0.02 | −0.4 | −0.04 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 39%
- 5 Years
- −32%
- 3 Years
- 24%
- TTM
- −61%
- 10 Years
- 42%
- 5 Years
- 35%
- 3 Years
- 82%
- TTM
- −156%
- 10 Years
- 2%
- 5 Years
- 42%
- 3 Years
- 4%
- TTM
- —
- 10 Years
- 0%
- 5 Years
- 0%
- 3 Years
- 1%
- TTM
- —
Peers
Listed companies in the same business.
| Prism Medico and Pharmacy | ₹ 35.20 | ₹ 42 Cr. | 251.2x | 1.2x | 2% | — |
| Hindustan Unilever | ₹ 1,820.00 | ₹ 4,27,626 Cr. | 48.2x | 10.3x | 21.5% | 16.1% |
| Marico | ₹ 764.10 | ₹ 99,347 Cr. | 63x | 26.3x | 43.1% | 13.3% |
| Godrej Consumer Products | ₹ 851.50 | ₹ 87,134 Cr. | 53.8x | 8.6x | 15.1% | 12.3% |
| Dabur India | ₹ 366.00 | ₹ 64,927 Cr. | 39.9x | 6.6x | 17.1% | 14.2% |
| Cupid | ₹ 306.50 | ₹ 41,214 Cr. | 262.4x | 61.8x | 27.3% | 30.3% |
Management
- Bharat Singh
- Chief Financial Officer
- Sameer Gupta
- Compliance Officer, Company Secretary
- Sakhi Laller
- Whole Time Director
- Sachin Sharma
- Executive Director
- Jasjot Singh
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.